- Home
- NBIX vs CX Comparison
NBIX vs CX Comparison
Compare NBIX & CX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBIX | CX |
|---|---|---|
| Founded | 1992 | 1906 |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Building Materials |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 14.7B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | NBIX | CX |
|---|---|---|
| Price | $130.43 | $12.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 7 |
| Target Price | ★ $175.95 | $11.29 |
| AVG Volume (30 Days) | 1.2M | ★ 6.7M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.70% |
| EPS Growth | ★ 41.95 | N/A |
| EPS | ★ 4.67 | N/A |
| Revenue | ★ $161,626,000.00 | N/A |
| Revenue This Year | $22.57 | $8.07 |
| Revenue Next Year | $9.56 | $4.19 |
| P/E Ratio | $27.47 | ★ $19.03 |
| Revenue Growth | ★ 977.51 | N/A |
| 52 Week Low | $84.23 | $4.89 |
| 52 Week High | $160.18 | $13.35 |
Technical Indicators
Market Signals| Indicator | NBIX | CX |
|---|---|---|
| Relative Strength Index (RSI) | 42.87 | 53.51 |
| Support Level | $122.14 | $12.19 |
| Resistance Level | $129.94 | $12.82 |
| Average True Range (ATR) | 4.39 | 0.48 |
| MACD | -0.72 | -0.04 |
| Stochastic Oscillator | 39.90 | 65.92 |
Price Performance
Historical ComparisonAbout NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About CX Cemex S.A.B. de C.V. Sponsored ADR
Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and also provide related services and reliable construction-related services to customers and communities and maintain business relationships in more than 60 countries throughout the world. The company operates in different parts of the world, with operations in Mexico, the United States, the EMEA region and the SCA&C region.